What Is the Role of Beta-Agonist Bronchodilators in the Day-to-Day Treatment of Chronic Asthma?
The reported links of asthma morbidity and mortality to the use of in haled beta-agonist bronchodilators are reviewed. Reports from the Saskatchewan Asthma Epidemiology Project (SAEP) suggest that it is excessive use that is linked to life-threatening asthma and that patients at highest risk can be...
Saved in:
Main Author: | Pierre Ernst |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1995-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/1995/396751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overreliance on Bronchodilators as a Risk Factor for Life-Threatening Asthma
by: Pierre Ernst, et al.
Published: (1995-01-01) -
Circulating microRNAs associated with bronchodilator response in childhood asthma
by: Rinku Sharma, et al.
Published: (2024-11-01) -
Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD
by: Zsófia Lázár, et al.
Published: (2024-12-01) -
Adherence in patients with chronic treatment: data of “adherence day 2013”
by: Olatz Ibarra Barrueta, et al.
Published: (2015-01-01) -
Day by Day Baby Care /
by: Stoppard, Miriam
Published: (1985)